Literature DB >> 15295358

Patient characteristics that are associated with continued pessary use versus surgery after 1 year.

Jeffrey L Clemons1, Vivian C Aguilar, Eric R Sokol, Neil D Jackson, Deborah L Myers.   

Abstract

OBJECTIVE: The purpose of this study was to identify patient characteristics in women with symptomatic pelvic organ prolapse that is associated with continued pessary use versus surgery after 1 year. STUDY
DESIGN: Fifty-nine women with symptomatic pelvic organ prolapse who were satisfied with their pessary at 2 months were evaluated prospectively at 1 year. Characteristics of women who continued to use a pessary were compared with women who underwent pelvic reconstructive surgery to identify predictors for continued pessary use versus surgery.
RESULTS: Forty-three women (73%) continued pessary use, and 16 women (27%) underwent surgery. Characteristics that were associated with continued pessary use were older age (76 vs 61 years; p <.001) and poor surgical risk (26% vs 0%; P =.03). Characteristics that were associated with surgery were sexual activity (81% vs 26%; P <.001), stress incontinence (44% vs 16%; P =.03), stage III-IV posterior vaginal wall prolapse (44% vs 16%; P =.03), and desire for surgery at the first visit (63% vs 12%; P <.001). Age >or=65 years was the best cut-off value for continued pessary use, with sensitivity of 95% (95% CI, 84%, 99%) and a positive predictive value of 87% (95% CI, 74%, 94%). Logistic regression demonstrated that age >or=65 years ( P <.001), stage III-IV posterior vaginal wall prolapse ( P =.007), and desire for surgery ( P =.04) were independent predictors.
CONCLUSION: Age >or=65 years was associated highly with continued pessary use. Desire for surgery and stage III-IV posterior vaginal wall prolapse were associated with discontinued pessary use and pelvic reconstructive surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15295358     DOI: 10.1016/j.ajog.2004.04.048

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  22 in total

1.  Conservative treatment for female stress urinary incontinence: simple, reasonable and safe.

Authors:  Boris Friedman
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

2.  Pessary use in pelvic organ prolapse and urinary incontinence.

Authors:  Keisha A Jones; Oz Harmanli
Journal:  Rev Obstet Gynecol       Date:  2010

Review 3.  An integrative review and severity classification of complications related to pessary use in the treatment of female pelvic organ prolapse.

Authors:  Marwa Abdulaziz; Lynn Stothers; Darren Lazare; Andrew Macnab
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

4.  Diagnosis and Therapy of Female Pelvic Organ Prolapse. Guideline of the DGGG, SGGG and OEGGG (S2e-Level, AWMF Registry Number 015/006, April 2016).

Authors:  K Baeßler; T Aigmüller; S Albrich; C Anthuber; D Finas; T Fink; C Fünfgeld; B Gabriel; U Henscher; F H Hetzer; M Hübner; B Junginger; K Jundt; S Kropshofer; A Kuhn; L Logé; G Nauman; U Peschers; T Pfiffer; O Schwandner; A Strauss; R Tunn; V Viereck
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-12       Impact factor: 2.915

Review 5.  Pessaries (mechanical devices) for pelvic organ prolapse in women.

Authors:  Carol Bugge; Elisabeth J Adams; Deepa Gopinath; Fiona Reid
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

6.  Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.

Authors:  Theerarat Yimphong; Teerayut Temtanakitpaisan; Pranom Buppasiri; Chompilas Chongsomchai; Supparaluck Kanchaiyaphum
Journal:  Int Urogynecol J       Date:  2017-08-16       Impact factor: 2.894

7.  Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.

Authors:  Sophie Ramsay; Le Mai Tu; Cara Tannenbaum
Journal:  Int Urogynecol J       Date:  2016-02-12       Impact factor: 2.894

8.  Treatment strategies for pelvic organ prolapse: a cost-effectiveness analysis.

Authors:  Kathie L Hullfish; Elisa R Trowbridge; George J Stukenborg
Journal:  Int Urogynecol J       Date:  2011-03-01       Impact factor: 2.894

9.  Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.

Authors:  Birte Wolff; Kathryn Williams; Allen Winkler; Lawrence Lind; Dara Shalom
Journal:  Int Urogynecol J       Date:  2016-12-10       Impact factor: 2.894

10.  The pessary process: Spanish-speaking Latinas' experience.

Authors:  Claudia Sevilla; Cecilia K Wieslander; Alexandriah Alas; Gena Dunivan; Aqsa Khan; Sally Maliski; Rebecca Rogers; Jennifer T Anger
Journal:  Int Urogynecol J       Date:  2012-12-04       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.